Cyclopentolate en es it fr

Cyclopentolate Brand names, Cyclopentolate Analogs

Cyclopentolate Brand Names Mixture

  • No information avaliable

Cyclopentolate Chemical_Formula


Cyclopentolate RX_link

No information avaliable

Cyclopentolate fda sheet

Cyclopentolate msds (material safety sheet)

Cyclopentolate MSDS

Cyclopentolate Synthesis Reference

No information avaliable

Cyclopentolate Molecular Weight

291.385 g/mol

Cyclopentolate Melting Point

139 oC (hydrochloride salt)

Cyclopentolate H2O Solubility

No information avaliable

Cyclopentolate State


Cyclopentolate LogP


Cyclopentolate Dosage Forms

Ophthalmic solution (eye drops)

Cyclopentolate Indication

Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.

Cyclopentolate Pharmacology

Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.

Cyclopentolate Absorption

Absorbed following ophthalmic administration.

Cyclopentolate side effects and Toxicity

Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.

Cyclopentolate Patient Information

No information avaliable

Cyclopentolate Organisms Affected

Humans and other mammals